Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N MAini

Showing results (251-260 of 257) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 257 results.
Arthritis and Rheumatism|September 29, 1998
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritisR N Maini, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|April 13, 2004
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexateR N Maini, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|March 1, 1997
Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blottingJ S Smolen, B Butcher, M J Fritzler, et al.
The New England Journal of Medicine|November 30, 2000
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study GroupP E Lipsky, D M van der Heijde, E W St Clair, et al.
Annals of the Rheumatic Diseases|July 3, 2008
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockadeJ S Smolen, C Han, D M F M van der Heijde, et al.
Arthritis and Rheumatism|October 27, 1997
Range of antinuclear antibodies in "healthy" individualsE M Tan, T E Feltkamp, J S Smolen, et al.
Arthritis and Rheumatism|March 24, 1999
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificityE M Tan, J S Smolen, J S McDougal, et al.
Pageof 26

Showing results (251-260 of 257) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 257 results.
Arthritis and Rheumatism|September 29, 1998
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritisR N Maini, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|April 13, 2004
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexateR N Maini, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|March 1, 1997
Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blottingJ S Smolen, B Butcher, M J Fritzler, et al.
The New England Journal of Medicine|November 30, 2000
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study GroupP E Lipsky, D M van der Heijde, E W St Clair, et al.
Annals of the Rheumatic Diseases|July 3, 2008
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockadeJ S Smolen, C Han, D M F M van der Heijde, et al.
Arthritis and Rheumatism|October 27, 1997
Range of antinuclear antibodies in "healthy" individualsE M Tan, T E Feltkamp, J S Smolen, et al.
Arthritis and Rheumatism|March 24, 1999
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificityE M Tan, J S Smolen, J S McDougal, et al.
Pageof 26